A Houston company has seen a spike in sales in their on-demand fitness training sessions, and the startup is adding features to help users stay sane and healthy while stuck inside. Photo courtesy of Kanthaka

Last week, Sylvia Kampshoff saw a spike in her sales — something very uncommon for companies at this time, unless they are selling hand sanitizer, face masks, or toilet paper.

Kampshoff's company isn't providing toiletries though. Houston-based Kanthaka is an on-demand personal trainer tool for users to book one-on-one sessions with fitness experts at their own homes. With the city of Houston announcing that all bars and restaurants close to patrons, fitness studios followed suit. And that for Kanthaka meant a rise in sessions bought in Houston, Austin, Denver, Chicago, or any of the fifteen cities the app has launched in.

While gyms might be closing, "people feel pretty safe about having people come into their home," Kampshoff says, "and on the other hand we are wanting to give more jobs to trainers who have lost their jobs."

Kanthaka now has two people on boarding new fitness professionals on the app, and trainers who are out of work because their gym closed can get in touch with Kanthaka about the opportunity.

This spike in sales is coming mostly from younger users — particularly those in their 20s — but usually, Kanthaka has about a third of its users in the 60 and up age group — a population of people most at-risk from the COVID-19, or coronavirus. With this in mind, Kampshoff started looking into non face-to-face options for people who aren't comfortable with in-home instruction.

Next week, Kampshoff will launch digital sessions on Kanthaka. The sessions will still be one-on-one, but virtual. They won't be any cheaper, but will still provide that individual, undivided attention from a professional trainer. Additionally, Kanthaka will host free group fitness broadcasts online, and some will even factor in kids who are also stuck inside without many options for activities.

In just one week, Kampshoff had to pivot and tap a third-party streaming provider for the new service, something she has been able to do thanks to Sputnik ATX, an Austin-based accelerator Kampshoff is a part of.

"They were the first ones to say, 'Hey you should go virtual,'" Kampshoff says. "We started talking about it for the first time on Friday."

Ultimately, Kampshoff hopes this pivot will allow people access to personal training, as well as provide work for fitness professionals during the uncertain times of the coronavirus outbreak.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Biosciences startup becomes Texas' first decacorn after latest funding

A Dallas-based biosciences startup whose backers include millionaire investors from Austin and Dallas has reached decacorn status — a valuation of at least $10 billion — after hauling in a series C funding round of $200 million, the company announced this month. Colossal Biosciences is reportedly the first Texas startup to rise to the decacorn level.

Colossal, which specializes in genetic engineering technology designed to bring back or protect various species, received the $200 million from TWG Global, an investment conglomerate led by billionaire investors Mark Walter and Thomas Tull. Walter is part owner of Major League Baseball’s Los Angeles Dodgers, and Tull is part owner of the NFL’s Pittsburgh Steelers.

Among the projects Colossal is tackling is the resurrection of three extinct animals — the dodo bird, Tasmanian tiger and woolly mammoth — through the use of DNA and genomics.

The latest round of funding values Colossal at $10.2 billion. Since launching in 2021, the startup has raised $435 million in venture capital.

In addition to Walter and Tull, Colossal’s investors include prominent video game developer Richard Garriott of Austin and private equity veteran Victor Vescov of Dallas. The two millionaires are known for their exploits as undersea explorers and tourist astronauts.

Aside from Colossal’s ties to Dallas and Austin, the startup has a Houston connection.

The company teamed up with Baylor College of Medicine researcher Paul Ling to develop a vaccine for elephant endotheliotropic herpesvirus (EEHV), the deadliest disease among young elephants. In partnership with the Houston Zoo, Ling’s lab at the Baylor College of Medicine has set up a research program that focuses on diagnosing and treating EEHV, and on coming up with a vaccine to protect elephants against the disease. Ling and the BCMe are members of the North American EEHV Advisory Group.

Colossal operates research labs Dallas, Boston and Melbourne, Australia.

“Colossal is the leading company working at the intersection of AI, computational biology, and genetic engineering for both de-extinction and species preservation,” Walter, CEO of TWG Globa, said in a news release. “Colossal has assembled a world-class team that has already driven, in a short period of time, significant technology innovations and impact in advancing conservation, which is a core value of TWG Global.”

Well-known genetics researcher George Church, co-founder of Colossal, calls the startup “a revolutionary genetics company making science fiction into science fact.”

“We are creating the technology to build de-extinction science and scale conservation biology,” he added, “particularly for endangered and at-risk species.”

Houston investment firm names tech exec as new partner

new hire

Houston tech executive Robert Kester has joined Houston-based Veriten, an energy-focused research, investment and strategy firm, as technology and innovation partner.

Kester most recently served as chief technology officer for emissions solutions at Honeywell Process Solutions, where he worked for five years. Honeywell International acquired Houston-based oil and gas technology company Rebellion Photonics, where Kester was co-founder and CEO, in 2019.

Honeywell Process Solutions shares offices in Houston with the global headquarters of Honeywell Performance Materials and Technologies. Honeywell, a Fortune 100 conglomerate, employs more than 850 people in Houston.

“We are thrilled to welcome Robert to the Veriten team,” founder and CEO Maynard Holt said in a statement, “and are confident that his technical expertise and skills will make a big contribution to Veriten’s partner and investor community. He will [oversee] every aspect of what we do, with the use case for AI in energy high on the 2025 priority list.”

Kester earned a doctoral degree in bioengineering from Rice University, a master’s degree in optical sciences from the University of Arizona and a bachelor’s degree in laser optical engineering technology from the Oregon Institute of Technology. He holds 25 patents and has more than 25 patents pending.

Veriten celebrated its third anniversary on January 10, the day that the hiring of Kester was announced. The startup launched with seven employees.

“With the addition of Dr. Kester, we are a 26-person team and are as enthusiastic as ever about improving the energy dialogue and researching the future paths for energy,” Holt added.

Kester spoke on the Houston Innovators Podcast in 2021. Listen here

.